Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Astrazeneca Says Ultomiris Granted Priority Review In US As Treatment For Adults With Immunoglobulin A Nephropathy

    Picture of AstraZeneca logoAstraZeneca
    15/06/2026 07:33
    BRIEF-Astrazeneca Says Ultomiris Granted Priority Review In US As Treatment For Adults With Immunoglobulin A Nephropathy
    June 15 (Reuters) - AstraZeneca PLC AZN.L:
    • ASTRAZENECA: ULTOMIRIS GRANTED PRIORITY REVIEW IN US AS TREATMENT FOR ADULTS WITH IMMUNOGLOBULIN A NEPHROPATHY
    Source text: [ID:]
    Further company coverage: AZN.L

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on AstraZeneca

    See all news